Personnel Information

写真a

TAGUCHI Towako


Job title

Assistant Professor

Mail Address

The inquiry by e-mail is 《here

Campus Career 【 display / non-display

  • 2017.04
    -
    2021.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Comprehensive Pathology, Graduate Student
  • 2021.07
    -
    2022.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Comprehensive Pathology, Visiting Lecturer
  • 2022.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Comprehensive Pathology, Assistant Professor
 

Published Papers & Misc 【 display / non-display

  1. Mori S, Ai T, Taguchi T, Negi M, Otomo Y. Aggressive diffuse large B-cell lymphoma manifested by splenic rupture progressed 2 months after transverse myelitis: an autopsy case report. Acute medicine & surgery. 2023.01; 10 (1): e822. ( PubMed, DOI )

  2. Hanabusa Y, Nakamura H, Aoki K, Makita K, Taguchi T, Arao K. Infective Arteritis Manifesting as an Acute Subdural Hematoma. Internal medicine (Tokyo, Japan). 2022.09; ( PubMed, DOI )

  3. Yuko Kinowaki, Towako Taguchi, Iichiroh Onishi, Susumu Kirimura, Masanobu Kitagawa, Kouhei Yamamoto. Overview of Ferroptosis and Synthetic Lethality Strategies. Int J Mol Sci. 2021.08; 22 (17): ( PubMed, DOI )

  4. Towako Taguchi, Morito Kurata, Iichiroh Onishi, Yuko Kinowaki, Yunosuke Sato, Sayuri Shiono, Sachiko Ishibashi, Masumi Ikeda, Masahide Yamamoto, Masanobu Kitagawa, Kouhei Yamamoto. SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma. Lab Invest. 2021.02; 101 (2): 218-227. ( PubMed, DOI )

Conference Activities & Talks 【 display / non-display

  1. 田口 登和子, 山本 浩平, 木脇 祐子, 大西 威一郎, 倉田 盛人, 山本 正英, 北川 昌伸. びまん性大細胞性リンパ腫においてSECISBP2はセレノプロテインを調整する新規の予後予測因子になりうる. 日本癌学会総会記事 2020.10.01